Mesoblast
MESO
#4315
Rank
NZ$4.22 B
Marketcap
NZ$32.84
Share price
1.36%
Change (1 day)
77.49%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : NZ$0.27 Billion

According to Mesoblast 's latest financial reports the company has NZ$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30NZ$0.10 B-11.29%
2023-06-30NZ$0.11 B20.19%
2022-06-30NZ$96.2 M-50.66%
2021-06-30NZ$0.19 B-2.42%
2020-06-30NZ$0.19 B168.68%
2019-06-30NZ$74.37 M35.32%
2018-06-30NZ$54.96 M421.09%
2017-06-30NZ$10.54 M-65.57%
2016-06-30NZ$30.63 M-1.59%
2015-06-30NZ$31.12 M612.72%
2014-06-30NZ$4.36 M-57.09%
2013-06-30NZ$10.17 M488.44%
2012-06-30NZ$1.72 M-99.46%
2011-06-30NZ$0.31 B585.83%
2010-06-30NZ$46.33 M79.74%
2009-06-30NZ$25.77 M39.14%
2008-06-30NZ$18.52 M18.14%
2007-06-30NZ$15.68 M20.91%
2006-06-30NZ$12.96 M-41.23%
2005-06-30NZ$22.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
NZ$3.83 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ$0.22 M-99.92% Bahamas